Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

People with limited treatment options

Booster HIV Drug Can Be Dropped

Editor's pick
MedPage Today
13 September 2012
New & experimental HIV treatments

Integrated analysis shows 'Quad' pill has potent activity with fewer side-effects

News
12 September 2012
Adherence

Combo Pills Fail to Get More HIV Patients on Meds

Editor's pick
MedPage Today
12 September 2012
New & experimental HIV treatments

Long-acting fusion inhibitor albuvirtide looks promising in early studies

News
11 September 2012
HIV prevention policy

'Test And Treat' Strategy For Curbing HIV Draws Questions

Editor's pick
NPR
11 September 2012
Weight gain & lipodystrophy

High rate of infections in people with HIV receiving Bio-Alcamid treatment for facial lipoatrophy

News
10 September 2012
Side effects

Salix Says FDA Decision Delayed on HIV-Associated Diarrhea Drug

Editor's pick
Bloomberg
6 September 2012
Pharmaceutical industry

High-End HIV Drug Stribild To Set Gilead Sciences Apart

Editor's pick
Seeking Alpha
6 September 2012
Cardiovascular disease

HIV and antiretroviral therapy increase risk of cardiovascular disease, shows meta-analysis

News
6 September 2012
Treatment outcomes & life expectancy

US: HIV Care, Outcomes Getting Better

Editor's pick
MedPage Today
5 September 2012
Treatment outcomes & life expectancy

Increased mortality in HIV-positive South African men versus women is unrelated to HIV/AIDS

Editor's pick
EurekAlert!
5 September 2012
Adherence

Near-perfect adherence needed to suppress cell-associated HIV

News
5 September 2012
Side effects

India: Safer anti-HIV drugs to replace Stavudine

Editor's pick
Indian Express
4 September 2012
Tuberculosis & HIV

TB control – a “common responsibility”, says ECDC Director

Editor's pick
ECDC press release
4 September 2012
Resistance

Decline in transmitted resistance to ARVs in UK leveled off in 2009

Editor's pick
International AIDS Society
3 September 2012
Resistance

Anti-HIV drug simulation offers 'realistic' tool to predict drug resistance and viral mutation

Editor's pick
Eurekalert Medicine & Health
3 September 2012
HIV treatment for children & young people

World's first HIV/AIDS nanomedicines

Editor's pick
Hospital Pharmacy Europe
3 September 2012
Hepatitis B

Viread labeling updates

Editor's pick
EATG
30 August 2012
Treatment guidelines

Brazil Expands Its Anti-AIDS Treatment Program

Editor's pick
New York Times
30 August 2012
Kidney problems

Atazanavir/ritonavir more likely to cause kidney stones than other ritonavir-boosted protease inhibitors

News
29 August 2012
Pharmaceutical industry

Quad approved in US: exorbitant cost likely to block use in Europe

Editor's pick
HIV i-Base
28 August 2012
New & experimental HIV treatments

F.D.A. Approves Once-a-Day Pill for H.I.V.

Editor's pick
New York Times
28 August 2012
New & experimental HIV treatments

Attachment inhibitor BMS-663068 does well in early study involving HIV-positive people

News
28 August 2012
Adherence

"Treatment partners" improve short-term virologic outcomes in those starting HIV therapy

News
27 August 2012